SCHLAP1 and posterior cortical atrophy: However, none of them has been yet introduced into clinical practice because of the variable expression incidence, as for SChLAP1 detected in 25% of PCa cases presenting metastatic traits (Prensner et al, 2013), or low specificity, as PCAT1 or PCAT7, thus infringing their clinical value.